DaVita (DVA)
(Real Time Quote from BATS)
$150.70 USD
+1.82 (1.22%)
Updated Aug 15, 2024 10:00 AM ET
2-Buy of 5 2
A Value B Growth B Momentum A VGM
Brokerage Reports
DaVita Inc. [DVA]
Reports for Purchase
Showing records 141 - 160 ( 289 total )
Company: DaVita Inc.
Industry: Medical - Outpatient and Home Healthcare
Company: DaVita Inc.
Industry: Medical - Outpatient and Home Healthcare
Company: DaVita Inc.
Industry: Medical - Outpatient and Home Healthcare
Company: DaVita Inc.
Industry: Medical - Outpatient and Home Healthcare
Company: DaVita Inc.
Industry: Medical - Outpatient and Home Healthcare
Company: DaVita Inc.
Industry: Medical - Outpatient and Home Healthcare
Research Summary
Provider: KEYBANC CAPITAL MARKETS
Company: DaVita Inc.
Industry: Medical - Outpatient and Home Healthcare
Company: DaVita Inc.
Industry: Medical - Outpatient and Home Healthcare
Company: DaVita Inc.
Industry: Medical - Outpatient and Home Healthcare
Company: DaVita Inc.
Industry: Medical - Outpatient and Home Healthcare
Company: DaVita Inc.
Industry: Medical - Outpatient and Home Healthcare
Company: DaVita Inc.
Industry: Medical - Outpatient and Home Healthcare
Headwinds Appear Broader than Expected, but Legislation Could Be a Catalyst.
Provider: KEYBANC CAPITAL MARKETS
Analyst: GURDA J
Company: DaVita Inc.
Industry: Medical - Outpatient and Home Healthcare
Company: DaVita Inc.
Industry: Medical - Outpatient and Home Healthcare
Company: DaVita Inc.
Industry: Medical - Outpatient and Home Healthcare
Company: DaVita Inc.
Industry: Medical - Outpatient and Home Healthcare
Company: DaVita Inc.
Industry: Medical - Outpatient and Home Healthcare
Research Summary
Provider: KEYBANC CAPITAL MARKETS
Company: DaVita Inc.
Industry: Medical - Outpatient and Home Healthcare
Morning Meeting Notes
Provider: KEYBANC CAPITAL MARKETS
Company: DaVita Inc.
Industry: Medical - Outpatient and Home Healthcare
Reducing Estimates on Premium Assistance Developments
Provider: KEYBANC CAPITAL MARKETS
Analyst: GURDA J